Select
Proteinuria selectivity index in renal disease
Publication date: 1 January 2024Source: Clinica Chimica Acta, Volume 552Author(s): Wen Liu, Zhi-Hang Su, Qi-Jun Wan
Genetics of Congenital Heart Disease
Publication date: Available online 28 November 2023Source: Clinica Chimica ActaAuthor(s): Yuanqin Zhao, Wei Deng, Zhaoyue Wang, Yanxia Wang, Hongyu Zheng, Kun Zhou, Qian Xu, Le Bai, Huiting Liu, Zhong Ren, Zhisheng Jiang
Development and performance of a next generation sequencing (NGS) assay for monitoring of dd-cfDNA post solid organ transplantation
Publication date: Available online 10 November 2023Source: Clinica Chimica ActaAuthor(s): Linnéa Pettersson, Sofia Westerling, Venkat Talla, Anton Sendel, Lars Wennberg, Richard Olsson, Anders Hedrum, Dan Hauzenberger
3-Methylglutarylcarnitine: A biomarker of mitochondrial dysfunction
Publication date: 1 November 2023Source: Clinica Chimica Acta, Volume 551Author(s): Elizabeth A. Jennings, Zane H. Abi-Rached, Dylan E. Jones, Robert O. Ryan
Third-generation sequencing for genetic disease
Publication date: 1 November 2023Source: Clinica Chimica Acta, Volume 551Author(s): Xiaoting Ling, Chenghan Wang, Linlin Li, Liqiu Pan, Chaoyu Huang, Caixia Zhang, Yunhua Huang, Yuling Qiu, Faquan Lin, Yifang Huang
M-protein detection by mass spectrometry for minimal residual disease in multiple myeloma
Publication date: Available online 2 November 2023Source: Clinica Chimica ActaAuthor(s): Lihua Guan, Wei Su, Jian Zhong, Ling Qiu
The current status of lipoprotein (a) measurement in clinical biochemistry laboratories in the UK: Results of a 2021 national survey
Annals of Clinical Biochemistry, Ahead of Print. BackgroundLipoprotein(a) (Lp(a)) is now established as a causal risk factor for cardiovascular disease (CVD) and accurate laboratory measurement is of pivotal importance in reducing Lp(a) associated risk…
Total human chorionic gonadotropin is a more suitable diagnostic marker of gestational trophoblastic diseases than the free β-subunit of human chorionic gonadotropin
Publication date: Available online 6 November 2023Source: Practical Laboratory MedicineAuthor(s): Hirokazu Usui, Atsuko Mikiya, Eri Katayama, Natsuko Nakamura, Asuka Sato, Hideo Matsui, Makio Shozu, Kaori Koga
Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis
Key Points Question When does neuroaxonal pathology occur in people with multiple sclerosis (MS) who experience disability worsening? Findings In this cohort study including 1899 individuals, serum neurofilament light chain elevation, as a sign of accelerated neuroaxonal injury, was detected approximately 1 year preceding disability worsening events associated with relapses and 1 to 2 years before worsening … Read more